Drug
Highly active antiretroviral therapy (HAART)
Highly active antiretroviral therapy (HAART) is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
1
20%
Ph phase_4
2
40%
Ph phase_3
1
20%
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
Trials by Status
completed480%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
Anti-HIV Medications for People Recently Infected With HIV
NCT00106171
completedphase_4
IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women
NCT00955968
completedphase_1
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
NCT00705926
terminatedphase_3
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
NCT01467479
completedphase_2
The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin
NCT00031343
Clinical Trials (5)
Showing 5 of 5 trials
NCT00106171Phase 4
Anti-HIV Medications for People Recently Infected With HIV
NCT00955968Phase 4
IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women
NCT00705926Phase 1
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
NCT01467479Phase 3
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
NCT00031343Phase 2
The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5